171 related articles for article (PubMed ID: 2581148)
1. The interaction of McN-A-343 with pirenzepine and other selective muscarine receptor antagonists at a prejunctional muscarine receptor.
Choo LK; Mitchelson F; Vong YM
Naunyn Schmiedebergs Arch Pharmacol; 1985 Feb; 328(4):430-8. PubMed ID: 2581148
[TBL] [Abstract][Full Text] [Related]
2. Selective inhibition of responses to carbachol and McN-A-343 in the rabbit vas deferens.
Choo LK; Mitchelson F
Clin Exp Pharmacol Physiol; 1990 Sep; 17(9):601-11. PubMed ID: 1703935
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of field stimulation-induced contractions of rabbit vas deferens by muscarinic receptor agonists: selectivity of McN-A-343 for M1 receptors.
Davies RH; Scholes HE; Virdi S; Broadley KJ
J Pharm Pharmacol; 2001 Apr; 53(4):487-96. PubMed ID: 11341365
[TBL] [Abstract][Full Text] [Related]
4. Pharmacological analysis of the muscarinic receptors involved when McN-A 343 stimulates acid secretion in the mouse isolated stomach.
Black JW; Shankley NP
Br J Pharmacol; 1985 Nov; 86(3):609-17. PubMed ID: 2415197
[TBL] [Abstract][Full Text] [Related]
5. The putative M1 muscarinic receptor does not regulate phosphoinositide hydrolysis. Studies with pirenzepine and McN-A343 in chick heart and astrocytoma cells.
Brown JH; Goldstein D; Masters SB
Mol Pharmacol; 1985 May; 27(5):525-31. PubMed ID: 2581122
[TBL] [Abstract][Full Text] [Related]
6. Effect of temperature reduction on responsiveness to cholinomimetics in the taenia caeci of the guinea-pig.
Darroch SA; Gardner A; Vong YM; Choo LK; Mitchelson F
J Auton Pharmacol; 1991 Apr; 11(2):109-19. PubMed ID: 1710620
[TBL] [Abstract][Full Text] [Related]
7. Interaction of some muscarinic agonists and antagonists at the prejunctional muscarinic receptor in the rabbit ear artery preparation.
Choo LK; Mitchelson F; Vong YM
Br J Pharmacol; 1986 Apr; 87(4):733-40. PubMed ID: 3708206
[TBL] [Abstract][Full Text] [Related]
8. McN-A-343, a specific agonist of M1-muscarinic receptors, exerts antinicotinic and antimuscarinic effects in the rat adrenal medulla.
Wakade AR; Kahn R; Malhotra RK; Wakade CG; Wakade TD
Life Sci; 1986 Dec; 39(22):2073-80. PubMed ID: 2431246
[TBL] [Abstract][Full Text] [Related]
9. Characterization of the muscarine receptor type on paracrine cells activated by McN-A-343 in the mouse isolated stomach.
Kromer W; Baron E; Beinborn M; Boer R; Eltze M
Naunyn Schmiedebergs Arch Pharmacol; 1990 Mar; 341(3):165-70. PubMed ID: 1692974
[TBL] [Abstract][Full Text] [Related]
10. Pharmacologic identification, activation and antagonism of two muscarine receptor subtypes in the lower esophageal sphincter.
Gilbert R; Rattan S; Goyal RK
J Pharmacol Exp Ther; 1984 Aug; 230(2):284-91. PubMed ID: 6205136
[TBL] [Abstract][Full Text] [Related]
11. The interaction of McN-A-343 with muscarine receptors in cardiac and smooth muscle.
Elnatan A; Mitchelson F
Biochem Pharmacol; 1993 Sep; 46(6):993-1003. PubMed ID: 7692853
[TBL] [Abstract][Full Text] [Related]
12. Pharmacologic discrimination between receptor heterogeneity and allosteric interaction: resultant analysis of gallamine and pirenzepine antagonism of muscarinic responses in rat trachea.
Kenakin T; Boselli C
J Pharmacol Exp Ther; 1989 Sep; 250(3):944-52. PubMed ID: 2778720
[TBL] [Abstract][Full Text] [Related]
13. Emesis induced by 4-(m-chlorophenylcarbamoyloxy)-2-butynyltrimethylammonium chloride (McN-A-343): evidence for a predominant central muscarinic M1 mediation.
Beleslin DB; Nedelkovski V
Neuropharmacology; 1988 Sep; 27(9):949-56. PubMed ID: 2460797
[TBL] [Abstract][Full Text] [Related]
14. Dual effect of the muscarinic agonist McN-A-343 on vascular neuroeffector transmission.
Nedergaard OA
Acta Pharmacol Toxicol (Copenh); 1981 Nov; 49(5):354-65. PubMed ID: 6179387
[TBL] [Abstract][Full Text] [Related]
15. Characterization of the subtype of muscarinic receptor coupled to the stimulation of phosphoinositide hydrolysis in 132-1N1 human astrocytoma cells.
Stephan CC; Sastry BV
Cell Mol Biol (Noisy-le-grand); 1992 Nov; 38(7):701-12. PubMed ID: 1282058
[TBL] [Abstract][Full Text] [Related]
16. Postsynaptic integration of cholinergic and dopaminergic signals on medium-sized GABAergic projection neurons in the neostriatum.
Harsing LG; Zigmond MJ
Brain Res Bull; 1998 Apr; 45(6):607-13. PubMed ID: 9566505
[TBL] [Abstract][Full Text] [Related]
17. Functional partial agonism at cloned human muscarinic acetylcholine receptors.
Bräuner-Osborne H; Ebert B; Brann MR; Falch E; Krogsgaard-Larsen P
Eur J Pharmacol; 1996 Oct; 313(1-2):145-50. PubMed ID: 8905341
[TBL] [Abstract][Full Text] [Related]
18. Evidence for facilitatory and inhibitory muscarinic receptors on postganglionic sympathetic nerves in mouse isolated atria.
Cost M; Majewski H
Br J Pharmacol; 1991 Apr; 102(4):855-60. PubMed ID: 1713109
[TBL] [Abstract][Full Text] [Related]
19. Pirenzepine distinguishes between muscarinic receptor-mediated phosphoinositide breakdown and inhibition of adenylate cyclase.
Gil DW; Wolfe BB
J Pharmacol Exp Ther; 1985 Mar; 232(3):608-16. PubMed ID: 2579230
[TBL] [Abstract][Full Text] [Related]
20. Presynaptic M2-muscarinic receptors on noradrenergic nerve endings and endothelium-derived M3 receptors in cat cerebral arteries.
Alonso MJ; Arribas S; Marín J; Balfagón G; Salaices M
Brain Res; 1991 Dec; 567(1):76-82. PubMed ID: 1726141
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
